287 related articles for article (PubMed ID: 12907757)
1. High constitutive signaling of the ghrelin receptor--identification of a potent inverse agonist.
Holst B; Cygankiewicz A; Jensen TH; Ankersen M; Schwartz TW
Mol Endocrinol; 2003 Nov; 17(11):2201-10. PubMed ID: 12907757
[TBL] [Abstract][Full Text] [Related]
2. Ghrelin receptor inverse agonists: identification of an active peptide core and its interaction epitopes on the receptor.
Holst B; Lang M; Brandt E; Bach A; Howard A; Frimurer TM; Beck-Sickinger A; Schwartz TW
Mol Pharmacol; 2006 Sep; 70(3):936-46. PubMed ID: 16798937
[TBL] [Abstract][Full Text] [Related]
3. Nonpeptide and peptide growth hormone secretagogues act both as ghrelin receptor agonist and as positive or negative allosteric modulators of ghrelin signaling.
Holst B; Brandt E; Bach A; Heding A; Schwartz TW
Mol Endocrinol; 2005 Sep; 19(9):2400-11. PubMed ID: 15905359
[TBL] [Abstract][Full Text] [Related]
4. Common structural basis for constitutive activity of the ghrelin receptor family.
Holst B; Holliday ND; Bach A; Elling CE; Cox HM; Schwartz TW
J Biol Chem; 2004 Dec; 279(51):53806-17. PubMed ID: 15383539
[TBL] [Abstract][Full Text] [Related]
5. Ghrelin and growth hormone (GH) secretagogues potentiate GH-releasing hormone (GHRH)-induced cyclic adenosine 3',5'-monophosphate production in cells expressing transfected GHRH and GH secretagogue receptors.
Cunha SR; Mayo KE
Endocrinology; 2002 Dec; 143(12):4570-82. PubMed ID: 12446584
[TBL] [Abstract][Full Text] [Related]
6. GPR39 signaling is stimulated by zinc ions but not by obestatin.
Holst B; Egerod KL; Schild E; Vickers SP; Cheetham S; Gerlach LO; Storjohann L; Stidsen CE; Jones R; Beck-Sickinger AG; Schwartz TW
Endocrinology; 2007 Jan; 148(1):13-20. PubMed ID: 16959833
[TBL] [Abstract][Full Text] [Related]
7. Characterization of ghrelin receptor activity in a rat pituitary cell line RC-4B/C.
Falls HD; Dayton BD; Fry DG; Ogiela CA; Schaefer VG; Brodjian S; Reilly RM; Collins CA; Kaszubska W
J Mol Endocrinol; 2006 Aug; 37(1):51-62. PubMed ID: 16901923
[TBL] [Abstract][Full Text] [Related]
8. Ghrelin receptor: high constitutive activity and methods for developing inverse agonists.
Els S; Beck-Sickinger AG; Chollet C
Methods Enzymol; 2010; 485():103-21. PubMed ID: 21050913
[TBL] [Abstract][Full Text] [Related]
9. Modulation of the constitutive activity of the ghrelin receptor by use of pharmacological tools and mutagenesis.
Mokrosiński J; Holst B
Methods Enzymol; 2010; 484():53-73. PubMed ID: 21036226
[TBL] [Abstract][Full Text] [Related]
10. Agonist-specific coupling of growth hormone secretagogue receptor type 1a to different intracellular signaling systems. Role of adenosine.
Carreira MC; Camiña JP; Smith RG; Casanueva FF
Neuroendocrinology; 2004 Jan; 79(1):13-25. PubMed ID: 14755130
[TBL] [Abstract][Full Text] [Related]
11. Signal transduction mechanism of the seabream growth hormone secretagogue receptor.
Chan CB; Leung PK; Wise H; Cheng CH
FEBS Lett; 2004 Nov; 577(1-2):147-53. PubMed ID: 15527776
[TBL] [Abstract][Full Text] [Related]
12. Evidence against adenosine analogues being agonists at the growth hormone secretagogue receptor.
Johansson S; Fredholm BB; Hjort C; Morein T; Kull B; Hu PS
Biochem Pharmacol; 2005 Aug; 70(4):598-605. PubMed ID: 15979585
[TBL] [Abstract][Full Text] [Related]
13. High constitutive activity of a virus-encoded seven transmembrane receptor in the absence of the conserved DRY motif (Asp-Arg-Tyr) in transmembrane helix 3.
Rosenkilde MM; Kledal TN; Schwartz TW
Mol Pharmacol; 2005 Jul; 68(1):11-9. PubMed ID: 15788740
[TBL] [Abstract][Full Text] [Related]
14. Importance of constitutive activity and arrestin-independent mechanisms for intracellular trafficking of the ghrelin receptor.
Holliday ND; Holst B; Rodionova EA; Schwartz TW; Cox HM
Mol Endocrinol; 2007 Dec; 21(12):3100-12. PubMed ID: 17717076
[TBL] [Abstract][Full Text] [Related]
15. [The role of ghrelin in the regulation of energy homeostasis].
Otto Buczkowska E
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2005; 11(1):39-42. PubMed ID: 15850537
[TBL] [Abstract][Full Text] [Related]
16. Clinical pharmacology of human growth hormone and its secretagogues.
Root AW; Root MJ
Curr Drug Targets Immune Endocr Metabol Disord; 2002 Apr; 2(1):27-52. PubMed ID: 12477295
[TBL] [Abstract][Full Text] [Related]
17. Ghrelin control of GH secretion and feeding behaviour: the role of the GHS-R1a receptor studied in vivo and in vitro using novel non-peptide ligands.
Bresciani E; Tamiazzo L; Torsello A; Bulgarelli I; Rapetti D; Caporali S; Perrissoud D; Moulin A; Fehrentz JA; Martinez J; Locatelli V
Eat Weight Disord; 2008 Sep; 13(3):e67-74. PubMed ID: 19011367
[TBL] [Abstract][Full Text] [Related]
18. Endogenous ghrelin regulates episodic growth hormone (GH) secretion by amplifying GH Pulse amplitude: evidence from antagonism of the GH secretagogue-R1a receptor.
Zizzari P; Halem H; Taylor J; Dong JZ; Datta R; Culler MD; Epelbaum J; Bluet-Pajot MT
Endocrinology; 2005 Sep; 146(9):3836-42. PubMed ID: 15919752
[TBL] [Abstract][Full Text] [Related]
19. Activation of the ghrelin receptor is described by a privileged collective motion: a model for constitutive and agonist-induced activation of a sub-class A G-protein coupled receptor (GPCR).
Floquet N; M'Kadmi C; Perahia D; Gagne D; Bergé G; Marie J; Banères JL; Galleyrand JC; Fehrentz JA; Martinez J
J Mol Biol; 2010 Jan; 395(4):769-84. PubMed ID: 19782690
[TBL] [Abstract][Full Text] [Related]
20. In vivo characterization of high Basal signaling from the ghrelin receptor.
Petersen PS; Woldbye DP; Madsen AN; Egerod KL; Jin C; Lang M; Rasmussen M; Beck-Sickinger AG; Holst B
Endocrinology; 2009 Nov; 150(11):4920-30. PubMed ID: 19819980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
